Overexpression of ALKBH5 decreases TGFβR2 and SMAD3 expression and mRNA stability, while increasing SMAD6, resulting in reduced TGF-β signaling, EMT, and invasion of NSCLC cells. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.